Clearmind Medicine Inc. Common Shares Cash Flow-to-Debt Ratio
Clearmind Medicine Inc. Common Shares cash flow-to-debt ratio. Clearmind Medicine Inc. Common Shares (CMND) has a Cash Flow-to-Debt Ratio of -0.72x as of January 2026, meaning its operating cash flow of $-2.08 Million could theoretically repay -1% of its total liabilities ($2.90 Million) in one year. Check cash flow reinvestment rate of Clearmind Medicine Inc. Common Shares to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Clearmind Medicine Inc. Common Shares (2014–2025)
Cash flow-to-debt ratio of Clearmind Medicine Inc. Common Shares from 2014 to 2025. Historical debt coverage capacity for Clearmind Medicine Inc. Common Shares across 12 annual periods. See CMND net asset quality index to measure how much of total assets are equity-financed.
Clearmind Medicine Inc. Common Shares Cash Flow-to-Debt Ratio by Year (2014–2025)
Clearmind Medicine Inc. Common Shares cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Clearmind Medicine Inc. Common Shares. For the full cash flow conversion analysis, see CMND cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.97x | $-4.73 Million | $4.89 Million | ▲ +17.4% |
| 2024 | -1.17x | $-6.76 Million | $5.77 Million | ▲ +7.6% |
| 2023 | -1.27x | $-6.30 Million | $4.97 Million | ▲ +34.2% |
| 2022 | -1.93x | $-5.06 Million | $2.62 Million | ▲ +73.3% |
| 2021 | -7.21x | $-2.08 Million | $288.19K | ▲ +63.6% |
| 2020 | -19.79x | $-198.50K | $10.03K | ▼ -1299.9% |
| 2019 | -1.41x | $-47.85K | $33.85K | ▲ +89.8% |
| 2018 | -13.82x | $-80.48K | $5.83K | ▼ -7665.7% |
| 2017 | -0.18x | $-9.12K | $51.28K | ▲ +42.1% |
| 2016 | -0.31x | $-15.37K | $50.01K | ▲ +83.2% |
| 2015 | -1.83x | $-39.81K | $21.76K | ▼ -105.2% |
| 2014 | -0.89x | $-28.01K | $31.43K | — |